Leadership and Change Management: Anna Frisch Case Study

Leadership and change
management Anna Frisch
case study

Table of Contents
TASK 1 INTRODUCTION...................................................................................................................3
TASK 2 Causes & Triggers of Change:.................................................................................................3
TASK 3 Organisational, Social & Cultural Dimensions of Change:.....................................................5
TASK 4 Recommendations to Lead & Manage Change:......................................................................8
TASK 5 CONCLUSION.....................................................................................................................10
REFERENCES....................................................................................................................................11

TASK 1 INTRODUCTION
The German health-care sector is still one of the least costly and undergoes changes to
cheaper prices and preserve or enhance the efficiency of medical care services. The theory of
unity is the key theme of the regulation of health framework (Allison and Goethals, 2020).
This report covers the case study of Anna Frisch which tells about the organisational change.
Anna Frisch had sought to promote reform at Aesch AG, a major multinational manufacturer
of medical instruments for the healthcare sector. As a marketing manager, she also
recognised dramatic changes in German hospitality which requested that Aesch modified its
forms of understanding buyers. The current policy makers – the CEOs, CFO's or CIOs of
healthcare, who adopted a various sales logic will be tackled by Aesch, rather to meet the
basic requirements of physicians in hospitals.
In this case scenario, there are many key issues which is faced by her in the health
care industry such as reduction in the growth rate, they have to invest huge amount for the
equipment in the hospitals and clinics as they are not investing so much in their hospitals as
well as advancement in technology. In context to Aesch AG they decided to spend no more
on marketing budget to target the clinical users and adapted the C- level marketing in their
businesses. The data in the case gives much information about the position from the other
competitors such as GE and Siemens through the innovation, partnership as well as customer
outcomes which tell about the level in which Aesch sustain in the market. On the other hand,
there are major supplier features of selected industry such as clear vision, better quality,
price, global presence, and technology along with the customer service in order to retain the
new as well as existing users. This report covers cause for change and the types of changes
experienced, changes looking into the organisational, social and culture with the significance
of culture, recommendations which lead to manage the changes in business which reflect the
leadership problems, workers engagement and the development.
TASK 2 Causes & Triggers of Change:
AESCH AG
Political
Government support for hospitals to purchase new equipment is restricted.

Economic
 Market development is slow.
 In the healthcare sector, cost-cutting has resulted in financial gaps.
 Hospitals have filed for bankruptcy.
 Medical facilities are experiencing rising costs and decreasing sales.
Social
• Global footprint developed
• Nation's biggest medical distributors
Technological
• Leading player in radiology processes, in-vitro immunodiagnostics & public health care Information
systems.
Aesch AG is situated in Switzerland which has headquarters in the Zurich, Switzerland. This
is the biggest distributor in the industry of the health care sector. They supply various systems
such as for diagnostic, molecular and immunodiagnostics which develops the IT system in
the health care industry (Barr and Dowding, 2019). German industry Aesch AG has faced
many challenges in the sector which are mentioned below:
High level of spending: The healthcare expense issue is not a recent one. There are
several parties involved, from the fabricator to the supplier of prescription medicines to
beneficiary to the health insurer supplier, who have an important part to play in deciding the
cost of health treatment. The rise in healthcare costs has a significant impact on the income of
healthcare companies as higher costs deter patients in many respects from laboratory
examinations and routine join during a visit that eventually leads to bad medical results
(Bligh, Kohles and Yan, 2018).
Low GDP growth: This means that better economic performance countries have
legislative and creative policies to promote medical science, thus reducing clinicians'
expenses. Health expenses per capita and GDP per capita are classified by state such as in
Germany.
Advance technology: Learning are now already driving also automated systems used
in hospitals, such as the schedule control system, clinical administration system and data
management system which they have to adapt the advanced technologies such as AI and
artificial. In context to selected health care industry, the health officials and physicians have
to build stronger links with pharmaceutical suppliers and global innovation firms in order to